News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Monday, January 30, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point

      From Medscape Oncology

      Medscape Medical News from the:

      35th Annual San Antonio Breast Cancer Symposium (SABCS)

      December 04 - 08, 2012; San Antonio, Texas

      This coverage is not sanctioned by, nor a part of, the supporters of the San Antonio
      Breast Cancer Symposium      .

      Meeting Highlights at a Glance

      Top News From SABCS 2012: Slideshow
      Highlights of this year's conference include dramatic improvement in progression-free survival when an experimental cell-cycle inhibitor is added to letrozole; 10 years of adjuvant tamoxifen is worth it (the ATLAS study); and chemotherapy for an isolated breast cancer recurrence has value.

      Commentaries

      Making Headway in Brain Metastases
      Drs. Lidia Schapira and Nancy Lin discuss the most recent data on treatment and outcomes of central nervous system metastases in breast cancer.

      Issues in Treating Older Women With Breast Cancer
      Striking the balance between over- and undertreatment requires a special approach in older women with breast cancer.

      When Is Less Surgery Beneficial in Breast Cancer?
      Dr. Judy Boughey describes a technique that might spare many women the ordeal of axillary lymph node dissection.

      Is Breast Cancer More Deadly in the Young?
      Sibylle Loibl explains the special considerations for treating breast cancer in young women, including the treatment of breast cancer during pregnancy.

      Conference News

      Medscape Oncology©  WebMD, LLC

      Medscape Oncology Insights

      Everolimus: Avalanche of mTOR Data in ER+ Breast Cancer
      Lidia Schapira, MD;
      Fabrice André, MD, PhD

      Is Neoadjuvant BEV Right for Triple-Negative Disease?
      Lidia Schapira, MD;
      Gunter von Minckwitz, MD, PhD

      A New Way to Tackle Triple-Negative Breast Cancer?
      Kathy D. Miller, MD;
      Carlos L. Arteaga, MD

      ATLAS: No Shrugging These Results
      Kathy D. Miller, MD;
      Harold J. Burstein, MD

      HER2-Positive Disease: No Need for Chemo?
      Kathy D. Miller, MD;
      José M. Baselga, MD, PhD

      Local-Regional Control Improves Breast Cancer Survival
      Kathy D. Miller, MD;
      Thomas A. Buchholz, MD

      Pre-Meeting Expert Commentary

      SABCS Preview: Watch for Sentinel Node Studies
      Kathy D. Miller, MD

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.